Literature DB >> 22537912

Structural and functional analysis of native peroxiredoxin 2 in human red blood cells.

Yuki Ogasawara1, Takuya Ohminato, Yusuke Nakamura, Kazuyuki Ishii.   

Abstract

Peroxiredoxin 2, a typical 2-Cys peroxiredoxin, is the third most abundant protein in erythrocytes. It is understood that the physiologically functional state of peroxiredoxin 2 is the monomer, and that its role in scavenging low levels of H(2)O(2) results in the formation of disulfide-linked dimers, which are reversibly reduced to monomers by the thioredoxin-thioredoxin reductase system. Additionally, peroxiredoxins are highly susceptible to sulfinic acid formation through reactions with various peroxides. This overoxidized form, which is thought to convert peroxiredoxins into molecular chaperones and to be accompanied by a transition to polymeric forms, can be reversed by sulfiredoxins. However, physiological conformational changes and the antioxidant role of erythrocyte peroxiredoxin 2 are still unclear because there is low sulfiredoxin and thioredoxin-thioredoxin reductase activity in erythrocytes. In this study, we examined the structural and redox states of peroxiredoxin 2 in fresh hemolysates and estimated the activities of native and overoxidized peroxiredoxin 2 purified from red blood cells to clear the physiological roles of peroxiredoxin 2 in erythrocyte. Our findings demonstrate that native peroxiredoxin 2 exists as high molecular weight (>160 kDa) oligomers and that decamers or higher order molecular weight oligomers (260-460 kDa) have peroxidase activity. We further showed that peroxiredoxin 2 oligomers, which were predominantly composed of monomers in the reduced form, exert a chaperone activity equal to that of overoxidized peroxiredoxin 2 polymers. These results provide the novel insight that redox-active peroxiredoxin 2 functions in human red blood cells as high molecular weight oligomers that possess peroxidase and chaperone activities.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537912     DOI: 10.1016/j.biocel.2012.04.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

Review 1.  The Multifaceted Impact of Peroxiredoxins on Aging and Disease.

Authors:  Svetlana N Radyuk; William C Orr
Journal:  Antioxid Redox Signal       Date:  2018-01-17       Impact factor: 8.401

2.  Peroxidatic cysteine residue of peroxiredoxin 2 separated from human red blood cells treated by tert-butyl hydroperoxide is hyperoxidized into sulfinic and sulfonic acids.

Authors:  Yo-Ichi Ishida; Mariko Aki; Sohta Fujiwara; Masami Nagahama; Yuki Ogasawara
Journal:  Hum Cell       Date:  2017-04-22       Impact factor: 4.174

3.  Should autism be considered a canary bird telling that Homo sapiens may be on its way to extinction?

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-08-24

4.  Irreversible hyperoxidation of peroxiredoxin 2 is caused by tert-butyl hydroperoxide in human red blood cells.

Authors:  Y I Ishida; M Takikawa; T Suzuki; M Nagahama; Y Ogasawara
Journal:  FEBS Open Bio       Date:  2014-10-13       Impact factor: 2.693

Review 5.  Oxidative stress in β-thalassaemia and sickle cell disease.

Authors:  S Voskou; M Aslan; P Fanis; M Phylactides; M Kleanthous
Journal:  Redox Biol       Date:  2015-08-01       Impact factor: 11.799

6.  Organ-Specific Oxidative Events under Restrictive Versus Full Reperfusion Following Hemorrhagic Traumatic Shock in Rats.

Authors:  Carina Penzenstadler; Anna Zifko; Mohammad Jafarmadar; Janin Schulte; Joachim Struck; Michaela Stainer; Andrey Kozlov; Soheyl Bahrami
Journal:  Molecules       Date:  2018-08-30       Impact factor: 4.411

7.  Oxidation resistance 1 regulates post-translational modifications of peroxiredoxin 2 in the cerebellum.

Authors:  Daria M Svistunova; Jillian N Simon; Elzbieta Rembeza; Mark Crabtree; Wyatt W Yue; Peter L Oliver; Mattéa J Finelli
Journal:  Free Radic Biol Med       Date:  2018-10-31       Impact factor: 7.376

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.